Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26080335 | 0.77 | MAPT (0.37) | MAPTSMN1; SMN2PKMALDH1A1LMNA | |
| SCHEMBL18724534 | 0.77 | — | — | |
| SCHEMBL3121602 | 0.77 | — | — | |
| SCHEMBL3132292 | 0.75 | FDPS (0.36) | MAPTLMNA | |
| SCHEMBL7708081 | 0.74 | KCNA5 (0.32) | MAPTSMN1; SMN2PKMALDH1A1LMNA | |
| SCHEMBL7710676 | 0.74 | KCNA5 (0.32) | MAPTSMN1; SMN2PKMALDH1A1LMNA | |
| SCHEMBL7708077 | 0.74 | KCNA5 (0.32) | MAPTSMN1; SMN2PKMALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL11682972 | 0.73 | FDPS (0.34) | MAPTSMN1; SMN2ALDH1A1LMNAKMT2A | |
| SCHEMBL18724744 | 0.73 | MC4R (0.38) | ALDH1A1 | |
| SCHEMBL11288832 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 433 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119462617-B | Anti-ultraviolet agent, preparation method thereof, resin mixture and application thereof | 珠海莫界科技有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-3685231-B1 | 3D PRINTING WITH POLYMERIC NANOGEL PARTICLES | THE REGENTS OF THE UNIV OF COLORADO A BODY CORPORATE A COLORADO NON PROFIT (US) | 2026-05-13 | — | — | EP | claimed |
| US-20260055222-A1 | PHOTOCURABLE COMPOSITION AND ITS APPLICATION IN PHOTOCURING FIELDS | Huizhou Huahong New Materials Co., Ltd. (CN) | 2026-02-26 | — | — | US | claimed |
| EP-3864072-B1 | DUAL CURABLE ORGANOPOLYSILOXANE COMPOSITION | DOW SILICONES CORP (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4455168-B1 | VISIBLE LIGHT CURABLE COMPOSITION AND VISIBLE LIGHT CURABLE COMPOSITION POLYMERIZATION METHOD | CHT TURKEY KIMYA SANAYI VE TICARET A S (TR) | 2025-12-24 | — | — | EP | claimed |
| EP-4209277-B1 | DUAL SLOT DIE FOR SIMULTANEOUSLY PERFORMING ELECTRODE SLURRY COATING AND INSULATING SOLUTION COATING AND COATING METHOD USING THE SAME | LG ENERGY SOLUTION LTD (KR) | 2025-12-17 | — | — | EP | claimed |
| US-20250129196-A1 | PHOTOCURABLE COMPOSITIONS AND METHOD OF MANUFACTURING DISPLAY DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-04-24 | — | — | US | claimed |
| EP-4540300-A1 | HIGH HARDNESS, LOW VISCOSITY UV CURABLE POTTING ADHESIVE COMPOSITION | Henkel AG & Co. KGaA (DE) | 2025-04-23 | — | — | EP | claimed |
| US-20250115793-A1 | HIGH HARDNESS, LOW VISCOSITY UV CURABLE POTTING ADHESIVE COMPOSITION | HENKEL AG & CO KGAA (DE) | 2025-04-10 | — | — | US | claimed |
| EP-3932671-B1 | DUAL-CURING PHASE SEPARATION TYPE CONTINUOUS 3D PRINTING HIGH-PRECISION PHOTOSENSITIVE RESIN COMPOSITION | SUZHOU POLLY NEW MAT TECH CO LTD (CN) | 2025-03-19 | — | — | EP | claimed |
| EP-3610327-B1 | METHOD OF IMPROVING LIGHT STABILITY OF FLEXOGRAPHIC PRINTING PLATES FEATURING FLAT TOP DOTS | MACDERMID GRAPHICS SOLUTIONS LLC (US) | 2023-03-22 | — | — | EP | claimed |
| EP-3750967-B1 | ADHESIVE COMPOSITION | LG CHEMICAL LTD (KR) | 2023-03-08 | — | — | EP | claimed |
| WO-2022183601-A1 | UV CURABLE PRESSURE-SENSITIVE ADHESIVE | 深圳力合博汇光敏材料有限公司 | 2022-09-09 | — | — | WO | claimed |
| US-20120308646-A1 | TETRACYCLIC ANTHRAQUINONES POSSESSING ANTI-CANCER PROPERTIES | ZHANG HESHENG (CN) | 2012-12-06 | — | — | US | claimed |
| CN-102648230-A | Low-viscosity epoxy resin composition with low blushing | SIKA TECHNOLOGY AG | 2012-08-22 | — | — | CN | claimed |
| EP-1487806-B1 | 4-ANILINO QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS | ASTRAZENECA AB (SE) | 2010-07-07 | — | — | EP | claimed |
| US-20090325894-A1 | TETRACYCLIC ANTHRAQUINONES POSSESSING ANTI-CANCER PROPERTIES | ZHANG HESHENG | 2009-12-31 | — | — | US | claimed |
| EP-2123283-A1 | THE TETRACYCLIC ANTHRAQUINONES POSSESSING ANTI-CANCER EFFECT | Tianjin Hemey Bio-Tech Co., Ltd. (CN) | 2009-11-25 | — | — | EP | claimed |
| CN-101225094-A | Anthraquinones tetracyclic compound having anticancer activity | TIANJIN HEMEI BIOTECHNOLOGY CO (CN) | 2008-07-23 | — | — | CN | claimed |
| US-5610315-A | Process for the preparation of 6,7-diacyl-7-deacetylforskolin derivatives | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1997-03-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055222-A1 | PHOTOCURABLE COMPOSITION AND ITS APPLICATION IN PHOTOCURING FIELDS | HTR3D, EPB41, INTS9 | MAPT 77/4885SMN1; SMN2 3343/4885PKM 1248/4885 |
| US-20090325894-A1 | TETRACYCLIC ANTHRAQUINONES POSSESSING ANTI-CANCER PROPERTIES | GLS2, GLS, VIP | MAPT 3851/4885SMN1; SMN2 3573/4885PKM 2571/4885 |
| US-20120308646-A1 | TETRACYCLIC ANTHRAQUINONES POSSESSING ANTI-CANCER PROPERTIES | ALAD, SLC27A2, ANTXR2 | MAPT 4468/4885SMN1; SMN2 3372/4885PKM 2563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.